Consistently, through a tissue array analysis, Young Yeon Kim et al. demonstrated that DRP1 was significantly decreased in malignant colon and lung cancer tissues, whereas no changes in the DRP1 levels were observed in breast and prostate tumors [66]. Here, DNM1L is linked to prostate neoplasm.